Podcasts about axis advisors

NCPA's Ronna Hauser, senior vice president of policy and pharmacy affairs, talks with Antonio Ciaccia, president of 3 Axis Advisors, about his firm's newest research on how the Medicaid Drug Price Negotiation Program will leave independent pharmacies high and dry.

Antonio Ciaccia, President of 3 Axis Advisors, calls in to talk about the prices of prescriptions.

Antonio Ciaccia, President of 3 Axis Advisors says managers raised prescription prices for $7billion gain

Antonio Ciaccia of 3 Axis Advisors returns to the show to discuss reform updates of how pharmacy benefit managers (PBMs) affect prescription drug prices and their relationship with pharmacies, nationwide and here in New Hampshire.

In this episode, Antonio Ciaccia, CEO of 46Brooklyn Research and President of 3 Axis Advisors, discusses the urgent need for PBMs to be transparent about their pricing practices. Join us as we delve into the complexities of drug pricing and the importance of accountability in the pharmacy industry. https://www.46brooklyn.com/ https://www.bizofpharmpod.com/ https://www.parcelhealth.co/

In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients. Antonio Ciaccia, President, 3 Axis Advisors and CEO, 46brooklyn Research, an Ohio non-profit Corporation 46brooklyn Ohio Pharmacist Association 3 Axis Advisors Medicaid 340B Program 340B Litigation 340 Eligibility, HRSA Covered Entities Medicaid Drug Rebate Program Obamacare Indian Health Service "Money from Sick People," Report from 46Brooklyn Medicare Pharmacy Benefit Managers (PBMs) Jamie Robinson, Health Economist Medical terminology referenced in this episode: Novolog Questions or comments?Email us at comments@prescriptionforbetteraccess.com.Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

March 7, 2024 ~ Earlier this week, groups met at the White House to discuss what is causing the high costs of prescription drug prices. Antonio Ciacca, President of 3 Axis Advisors, joins Kevin and Tom discuss the meeting.

Antonio Ciaccia, President of 3 Axis Advisors, talks about large Pharmacy Benefit Manager (PBM) companies, their influence on prescription drug prices and how federal legislation aims to pass more savings and rebates onto the consumer.

Antonio Ciaccia, President of 3 Axis Advisors, talks about large Pharmacy Benefit Manager (PBM) companies, their influence on prescription drug prices and how federal legislation aims to pass more savings and rebates onto the consumer.

Today's guest include Rachel Bitecofer, Author of "Hit 'Em Where It Hurts" Antonio Ciaccia, President of 3 Axis Advisors, a leading expert on prescription drug price Garrard McClendon, Associate Professor at Chicago State University Geoffrey Corn, Former Judge Advocate General officer and director of the Center for Military Law and Policy at Texas Tech University

NHBR editors speak with NH State Rep Erica Layon (Derry, NH) and Antonio Ciaccia, president of 3 Axis Advisors, about the negative effects pharmacy benefit managers have on the cost of prescription drugs and the health care system as a whole.

Antonio Ciaccia, Lead Health Policy Expert and President of 3 Axis Advisors, talks about a news study by 3 Axis Advisors to determine just how prices are being set for prescription drugs.

Antonio Ciaccia, Lead Health Policy Expert and President of 3 Axis Advisors, talks about a news study by 3 Axis Advisors to determine just how prices are being set for prescription drugs.

Antonio Ciaccia is the President of 3 Axis Advisors. He was born and raised in pharmacy, Antonio has been crawling around pharmacies his entire life. After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management. 3 Axis Advisors brings unique approaches to address the individual needs of each or our clients. As researchers and investigators at heart, 3 Axis endeavors are laser-focused on discovery through data-driven analysis and deep industry expertise, resulting in innovative and unique solutions.  Our obsessive passion for understanding complex systems and our immersion in the prescription drug supply chain and the broader healthcare delivery system enables us to arm our clients with the tools they need to accomplish their goals. Reference:  Ohio regulator's proposed pharmacy rules draw mixed response  New regs meant to promote safety at understaffed stores https://ohiocapitaljournal.com/2023/10/02/ohio-regulators-proposed-pharmacy-rules-draw-mixed-response/ 

Antonio Ciaccia is the President of 3 Axis Advisors. He was born and raised in pharmacy, Antonio has been crawling around pharmacies his entire life. After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management. 3 Axis Advisors brings unique approaches to address the individual needs of each or our clients. As researchers and investigators at heart, 3 Axis endeavors are laser-focused on discovery through data-driven analysis and deep industry expertise, resulting in innovative and unique solutions.  Our obsessive passion for understanding complex systems and our immersion in the prescription drug supply chain and the broader healthcare delivery system enables us to arm our clients with the tools they need to accomplish their goals. Reference:  Ohio regulator's proposed pharmacy rules draw mixed response  New regs meant to promote safety at understaffed stores https://ohiocapitaljournal.com/2023/10/02/ohio-regulators-proposed-pharmacy-rules-draw-mixed-response/ 

House Energy and Commerce Committee cleared a PBM bill that seems to contain more transparency loopholes and makes more limited policy tweaks to the drug supply chain middleman than the Senate HELP Committee's bill, but the House-side legislation would pull back the curtain on specialty-drug reimbursement in a way the Senate version does not.  Two titans of PBM Reform join us today, returning guest Antonio Ciaccia with 3 Axis Advisors and Loretta Boesing with Unite for Safe Medications update our PBM Reform Podcast listeners with the latest progression in PBM Reform.  Reference:  PBM Reform: Vertical Integration, Specialty Drug Tracking Among Differences In House v. Senate Bills https://pink.pharmaintelligence.informa.com/PS148320/PBM-Reform-Vertical-Integration-Specialty-Drug-Tracking-Among-Differences-In-House-v-Senate-Bills 

House Energy and Commerce Committee cleared a PBM bill that seems to contain more transparency loopholes and makes more limited policy tweaks to the drug supply chain middleman than the Senate HELP Committee's bill, but the House-side legislation would pull back the curtain on specialty-drug reimbursement in a way the Senate version does not.  Two titans of PBM Reform join us today, returning guest Antonio Ciaccia with 3 Axis Advisors and Loretta Boesing with Unite for Safe Medications update our PBM Reform Podcast listeners with the latest progression in PBM Reform.  Reference:  PBM Reform: Vertical Integration, Specialty Drug Tracking Among Differences In House v. Senate Bills https://pink.pharmaintelligence.informa.com/PS148320/PBM-Reform-Vertical-Integration-Specialty-Drug-Tracking-Among-Differences-In-House-v-Senate-Bills 

Antonio Ciaccia & Ben Link, PharmD, 3 Axis Advisors and 46brooklyn discuss how the pharmacy market is impacted by vertical integration. https://www.3axisadvisors.com/ https://www.46brooklyn.com/

Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug costs by phasing in a cap for out-of-pocket costs and establishing a$35 cap for a month's supply of insulin. And, as an historic win, Medicare will be able to negotiate prices for high-cost drugs for the first time ever. Guests:  Mark Blum  Mark is the Executive Director of America's Agenda, an organization he's led since its founding in 2005. America's Agenda is a national healthcare alliance that brings together labor unions, businesses, healthcare providers, and policymakers who share a common commitment to smart policy and effective action to advance our mission of affordable, high-quality, readily accessible healthcare for every American. Mark currently serves on the State Health Benefits Value and is a former member of the Quality Task Force in New Jersey and previously worked as an economics professor as well as national director of organizing for the American Association of University Professors. He completed his graduate studies at the London School of Economics.   A major focus for Mark in recent years has been the Pharmacy Benefit Manager issues facing our country. Mark is a founding member of the PBM Accountability Project. He works tirelessly to educate the public and advance solutions to help redirect prescription drug savings from very high PBM profits back to patients, employee health plans, and taxpayers. Antonio Ciaccia Antonio Ciaccia (cha-cha) is the President of 3 Axis Advisors, a firm that among many things studies drug pricing. He was recently featured on NBC's Today Show talking about the lengths PBMs force independent pharmacies to go to find savings for their patients. He's also spoken publicly about PBMs in the context of the Inflation Reduction Act. Antonio has been in and around pharmacies his entire life. A graduate from The Ohio State University in 2007 with dual degrees in communications and political science. For six years he headed up government affairs for the Ohio Pharmacists Association. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug costs by phasing in a cap for out-of-pocket costs and establishing a$35 cap for a month's supply of insulin. And, as an historic win, Medicare will be able to negotiate prices for high-cost drugs for the first time ever. Guests:  Mark Blum  Mark is the Executive Director of America's Agenda, an organization he's led since its founding in 2005. America's Agenda is a national healthcare alliance that brings together labor unions, businesses, healthcare providers, and policymakers who share a common commitment to smart policy and effective action to advance our mission of affordable, high-quality, readily accessible healthcare for every American. Mark currently serves on the State Health Benefits Value and is a former member of the Quality Task Force in New Jersey and previously worked as an economics professor as well as national director of organizing for the American Association of University Professors. He completed his graduate studies at the London School of Economics.   A major focus for Mark in recent years has been the Pharmacy Benefit Manager issues facing our country. Mark is a founding member of the PBM Accountability Project. He works tirelessly to educate the public and advance solutions to help redirect prescription drug savings from very high PBM profits back to patients, employee health plans, and taxpayers. Antonio Ciaccia Antonio Ciaccia (cha-cha) is the President of 3 Axis Advisors, a firm that among many things studies drug pricing. He was recently featured on NBC's Today Show talking about the lengths PBMs force independent pharmacies to go to find savings for their patients. He's also spoken publicly about PBMs in the context of the Inflation Reduction Act. Antonio has been in and around pharmacies his entire life. A graduate from The Ohio State University in 2007 with dual degrees in communications and political science. For six years he headed up government affairs for the Ohio Pharmacists Association. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug costs by phasing in a cap for out-of-pocket costs and establishing a$35 cap for a month's supply of insulin. And, as an historic win, Medicare will be able to negotiate prices for high-cost drugs for the first time ever. Guests:  Mark Blum  Mark is the Executive Director of America's Agenda, an organization he's led since its founding in 2005. America's Agenda is a national healthcare alliance that brings together labor unions, businesses, healthcare providers, and policymakers who share a common commitment to smart policy and effective action to advance our mission of affordable, high-quality, readily accessible healthcare for every American. Mark currently serves on the State Health Benefits Value and is a former member of the Quality Task Force in New Jersey and previously worked as an economics professor as well as national director of organizing for the American Association of University Professors. He completed his graduate studies at the London School of Economics.   A major focus for Mark in recent years has been the Pharmacy Benefit Manager issues facing our country. Mark is a founding member of the PBM Accountability Project. He works tirelessly to educate the public and advance solutions to help redirect prescription drug savings from very high PBM profits back to patients, employee health plans, and taxpayers. Antonio Ciaccia Antonio Ciaccia (cha-cha) is the President of 3 Axis Advisors, a firm that among many things studies drug pricing. He was recently featured on NBC's Today Show talking about the lengths PBMs force independent pharmacies to go to find savings for their patients. He's also spoken publicly about PBMs in the context of the Inflation Reduction Act. Antonio has been in and around pharmacies his entire life. A graduate from The Ohio State University in 2007 with dual degrees in communications and political science. For six years he headed up government affairs for the Ohio Pharmacists Association. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Benefit Managers (PBMs) have become embedded in the ecosystem of drug pricing– but these middlemen are one of the reasons patients see high prices at the pharmacy counter. This episode is a crash course in everything drug pricing with a focus on PBMs, from their inception to their influence on health care costs. Guest Antonio Ciaccia, drug pricing researcher, explains how the key players of the drug supply chain, specifically PBMs, have impacted patients' access to transparent health care. Hosts: Terry Wilcox, Executive Director, Patients RisingDr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public InterestKate Pecora, Field CorrespondentGuests: Antonio Ciaccia, President of 3 Axis Advisors and Chief Executive Officer of 46brooklyn ResearchKelsey Feng, Correspondent Links: 46brooklyn Research3 Axis AdvisorsWhy Ryan Reynolds is telling people to get a colonoscopyIntellia's gene editing therapiesFree2Care ReportNeed help?The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.orgHave a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?Drop us a line: podcast@patientsrising.orgThe views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising, nor do the views and opinions stated on this show reflect the opinions of a guest's current or previous employers.

In this episode, our guest is Antonio Ciaccia, President of 3 Axis Advisors and CEO of 46brooklyn Research. Born and raised in the world of pharmacy, Antonio Ciaccia has been crawling around pharmacies his entire life. After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management, eventually heading up government affairs for the Ohio Pharmacists Association, where his data analytics work helped lead state officials to audit and uncover $244 million in hidden prescription drug overcharges in the state Medicaid managed care program. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining and more drugs were being excluded from plan coverage. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. Today, he serves as the President of 3 Axis Advisors, a consulting firm that works with Medicaid Fraud Control Units, provider groups, research firms, technology companies, law firms, investment analysts, employers, government agencies, benefit consultants, and private foundations to diagnose and eliminate inefficiencies and inappropriate incentives in the prescription drug supply chain. Within that capacity, he also serves as an advisor to the American Pharmacy Cooperative, Inc. (APCI) and the American Pharmacists Association (APhA). He is also the CEO and co-founder of 46brooklyn Research, a nonprofit organization dedicated to improving the transparency and accessibility of drug pricing data for the American public. Main Points: Drug pricing is way too complex, and many entities make money off that complexity. Unfortunately, industry consolidation and vertical integration has put many pharmacies in a tough spot, as their once reliable business model has now become increasingly compressed over time. Because pharmacy economics has been primarily derived from revenue harvested from filing prescriptions, the service of pharmacists has been overlooked and thrown into the drug pricing stew. Drug prices are currently being exploited by arbitrageurs, compromising pharmacy viability and their ability to provide a high level of service to patients. Arbitrage must be eliminated, and pharmacists should derive compensation from better aligned incentive structures that emphasize the delivery of value-added services. Guest - Antonio Ciaccia, President of 3 Axis Advisors and CEO of 46brooklyn Research -LinkedIn: https://www.linkedin.com/in/antonio-ciaccia-390879b/ -Instagram: @A_Ciaccia -Twitter: @A_Ciaccia -Website: https://www.3axisadvisors.com/ and https://www.46brooklyn.com/ Host - Hillary Blackburn, PharmD, MBA www.hillaryblackburn.com https://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook @HillBlackburn Twitter

Today's episode includes a recap of my weekend at the Ohio Pharmacist Association (OPA) Annual Conference April 1-3, 2022, and brief interviews with Ohio pharmacists Emlah Tubuo, PharmD and Greg Kramp, PharmD. Disclaimer.  I am an OPA Member, but I do not work for The Ohio Pharmacists Association.  The opinions mentioned in this podcast episode are my own and not necessarily those of OPA.  Also, I am not being compensated for any content in this podcast episode.   This episode has 4 parts.   In the first part, I'll give a recap from the sessions I attended:  session title and speaker(s) name(s), plus two take-aways. I attended 11 sessions and earned 16 hours of CE.  Ten sessions were 90 minutes long.  One was only 60 minutes long.  There were multiple offerings for each time slot, and it was hard to pick just one to attend. The second part is my interview with Emlah Tubuo, PharmD. The third part is my interview with Greg Kramp, PharmD. The fourth and final part of this episode will be a few stories about what went wrong back home while I was gone.  If you're a parent of teenagers, you're going to groan.  It has to do with my younger son missing the ACT on Saturday, April 2, and the death of the only houseplant I own.   Thank you for listening to The Pharmacist's Voice Podcast Episode 143! To read the full show notes, visit https://www.thepharmacistsvoice.com/podcast/ Mentioned in this episode Annual Meeting of the Ohio Pharmacists Association April 1-3, 2022 (Conference Brochure) OPA (Ohio Pharmacists Association) home page Emlah Tubuo, PharmD LinkedIn Profile  Emlah Naturals website  Emlah Naturals Instagram Page Greg Kramp, PharmD LinkedIn Profile Lauren Castle, Functional Medicine Pharmacists Alliance Founder www.notimpossible.com     Eye gaze goggles video (YouTube) Brian Bisher, Cincinnati-area pharmacist World Autism Day April 2, 2022 The Pharmacist's Voice Podcast Episode 75 with Dr. Adam Martin, The Fit Pharmacist The Pharmacist's Voice Podcast Episode 89 with Dr. Cory Jenks, Pharmacist, Improv Comedian, and Public Speaker The Pharmacist's Voice Podcast Episode 73 with Dr. Lauren Castle (Functional Medicine Pharmacist) The Pharmacist's Voice Podcast Episode 133 with Dan Krinsky, BS, Ms, RPH, FAPHA The Pharmacist's Voice Podcast Episode 135 with Sue Paul, RPH   Subscribe to or Follow The Pharmacist's Voice Podcast! Apple Podcasts Google Podcasts Spotify Amazon/Audible Friday Sessions Early Results from Provider Status Implementation with speakers Stu Beatty, Ana Hincapie, Anne Metzger, and Rebecca Lahrman.   OTC/Self-Care Challenge moderated by Kristine Cline and Max Conrad.  5 Ohio pharmacy schools competed in this Jeopardy/game-show-like competition: UC (the University of Cincinnati), NEOMED (Northeast Ohio Medical University), OSU (The Ohio State University), Findlay (the University of Findlay), and ONU (Ohio Northern University).  I did not see a team from my alma Mater The University of Toledo.  Cedarville University did not have a team either.   Current Trends in Prescription Drug Diversion with Dr. Donnie Sullivan.  Generation RX and You:  Medication Safety in Action, led by Ruth Emptage, Kelsey Schmuhl, and Tessa Miracle.  Saturday Sessions By the way, this was the best MORNING at OPA ever in the history of my attending the Annual Meetings.  I was inspired.  I was entertained.  I laughed. I learned.   Self-Care and Professional Well-Being:  The Prescription to Beat Burnout with speakers Dr. Adam Martin (The Fit Pharmacist) and Dr. Tim Ulbrich (Co-Founder & CEO of Your Financial Pharmacist). *VERY INSPIRATIONAL SESSION!* Putting “Yes, And” to Work:  Building a More Adaptable, Empathetic, and Humanizing Healthcare Experience with speaker Cory Jenks.  *This was by far THE MOST FUN CE SESSION I'VE EVER ATTENDED.  EVER!! Pharmacy's Role in Human Trafficking Awareness with speakers Karen Kier and 2022 PharmD Candidate Temi Omitowoju from Ohio Northern University.   National Human Trafficking Hotline is 1-888-3737-888   Text “INFO” or “HELP” to BeFree.  The digits are 233733   https://humantraffickinghotline.org/report-trafficking Successful Pharmacy Entrepreneurship with Marc Sweeney and Chris Antypas.   “Challenging times are great for innovation.”   Blue Ocean Strategy by W. Chan Kim and Renée Mauborgne.  Sunday sessions 2022 Legislative Update with four speakers:  Ernie Boyd (Executive Director of the Ohio Pharmacists Association), Michelle Fitzgibbon (a government relations professional), Dan Fitzpatrick (also a government affairs professional), and Antonio Ciaccia (CEO of 46 Brooklyn Research and 3 Axis Advisors). The 4 Pillars of Pharmacogenomics and Personalized Medicine with speakers Sue Paul, Dan Krinsky, and Amy Van Milligan, MD. Counterfeit Medicines in the US Supply Chain:  Learn How the Criminals Operate to Keep Your Patients Safe with non-pharmacist speaker Shabbir Safdar from the Partnership for Safe Medicines, which you can find at safemedicines.org. Dangerous Doses and Bottle of Lies by Katherine Eban were recommended by Mr. Safdar. Just a few things went wrong back home while I was away for 3 days. Gratitude first. The house did not burn down, and my husband and both kids were alive when I got home.    What went wrong? My son Derrick missed the ACT because he forgot about it. My only houseplant died a horrible death by wind, rain, and cold temps.  Our trash ended up in our recycling toter and the recyclables ended up in the trash toter. I left March 31, and no one flipped the calendars in the house to April.  No one printed the new lunch calendar for April either.   When my family went to church, no one brought the Noisy Change Offering, which is only collected the first Sunday of the month.  My son had to loan my husband cash so we could contribute toward the charity of the month.  My husband also forgot to pick his prescriptions up at the pharmacy on Saturday.  The pharmacy is closed Sunday. Better luck next time, boys!  Please laugh.  I know I did.  That's life, and life can be messy!  

Have you ever wondered why Medicare Part D has so many clawbacks? Say no more! The amazing folks at 3 Axis Advisors put together an amazing study that highlights this, how to fix it and do it with some amazingly easy to understand graphics! Dr. Ben Link and Dr. Matthew Wine are amazing guests and researchers on this episode who will give you the quick and dirty on their latest major report AND some actionable steps to fix it. What's the point of bringing problems to light if you don't have solutions? Link to the study discussed in most of the podcast: https://www.3axisadvisors.com/projects/2022/3/7/deserving-of-better-how-american-seniors-are-paying-for-misaligned-incentives-within-medicare-part-d-3aa Link to other 3 Axis Advisors work: https://www.3axisadvisors.com/projects Link to the 46 Brooklyn podcast: https://www.46brooklyn.com/podcast Where to find Dr. Link and Dr. Wine, personally: https://www.linkedin.com/in/benjaminjslink/ https://www.linkedin.com/in/matthew-wine-pharmd-mba-96092944/ Medicare Part D Explainer from Kaiser Family Foundation: https://www.kff.org/medicare/fact-sheet/an-overview-of-the-medicare-part-d-prescription-drug-benefit/ The 46 Brooklyn Copaxone study: https://www.46brooklyn.com/research/2020/8/12/copaxone Orange book: https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm

Pharmacy Benefit Managers (PBMs) are pouring gas on a fire they were hired to put out.  That's from Antonio Ciaccia, president of 3 Axis Advisors.who says PBMs have conflicts of interest in the drug chain and are collecting the discounts meant for consumers. You can follow this show on Instagram and on Facebook. And to see what Heather does when she's not talking money, go to her personal Twitter page. Be sure to email Heather your questions and request topics you'd like her to cover here. See omnystudio.com/listener for privacy information.

The entities charged with negotiating better drug prices for consumers are pocketing the savings for themselves.  Antonio Ciaccia, president of 3 Axis Advisors, explains how these little-known Pharmacy Benefit Managers (PBMs) became Fortune 15 companies. You can follow this show on Instagram and on Facebook. And to see what Heather does when she's not talking money, go to her personal Twitter page. Be sure to email Heather your questions and request topics you'd like her to cover here. See omnystudio.com/listener for privacy information.

Scott Knoer and Antonio Ciaccia discuss the advantages and challenges of fighting for pharmacy on a national level. https://www.pharmacist.com/ https://www.3axisadvisors.com/

Antonio Ciaccia exposes Pharmacy Benefit Managers (PBMs) and their drug pricing complicity. My question is, should PBMs even exist? Antonio Ciaccia, President of 3 Axis Advisors led government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency. Antonio has since spent years studying the pharmacy marketplace, publishing several analyses on the drug pricing code, and pulling the rug out from what he believes is one of the most dysfunctional marketplaces in the world. If you have health insurance, whether it be through Medicare, Medicaid, or private insurance, chances are it's managed by a PBM. They act as middlemen between drug manufacturers and patients' health plans, negotiating savings on prescription medicines and determining which drugs will be covered by insurance. However, PBMs fail to pass savings to the patients and insurance companies, while undermining the possibility for competition that would drive value and savings for consumers. This drives up the cost of prescription drugs, leaving you to pay more out of pocket. “With PBMs essentially centered at the core of the U.S. drug supply chain, it begs for scrutiny of how their business practices may exacerbate drug pricing dysfunction and excess,” said Mr. Ciacias. “As PBMs claim to be the only entity working to control drug prices, we believe that analyses like this report can shed light on the incentives and opportunities PBMs have to inflate costs rather than provide savings to plan sponsors and patients.”--- If you like what we do please do the following! Most Independent Media outlets continue to struggle to raise the funds they need to operate much like the smaller outlets like Politics Done Right SUBSCRIBE to our YouTube Channel here. LIKE our Facebook Page here. Share our blogs, podcasts, and videos. Get our books here. Become a YouTube PDR Posse Member here. Become a Politics Done Right Subscriber via Patreon here. Become a Politics Done Right Subscriber via Facebook here. Consider providing a contribution here. Please consider supporting our GoFundMe equipment fund here. --- Send in a voice message: https://anchor.fm/politicsdoneright/message Support this podcast: https://anchor.fm/politicsdoneright/support

Antonio Ciaccia exposes Pharmacy Benefit Managers (PBMs) and their drug pricing complicity. Joe Biden used real-world examples to sell Build Back Better. President of 3 Axis Advisor discusses his Pharmacy Benefit Managers PBM report 3axisadvisors com: Antonio Ciaccia (CHA CHA), President of 3 Axis Advisors. He led government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency. Antonio has since spent years studying the pharmacy marketplace, publishing several analyses on the drug pricing code and pulling the rug out from what he believes is one of the most dysfunctional marketplaces in the world. Joe Biden uses real world story to expose drug company thievery and to sell Build Back Better. ‘Utterly Obscene': Just 8 Pfizer and Moderna Investors Became $10 Billion Richer After Omicron Emerged: “Pharma execs and shareholders are making a killing from a crisis they helped to create,” said one justice campaigner. In the first week that the Omicron variant sparked global fears of a new wave of infections, a small handful of investors and executives with Pfizer and Moderna—currently the world's preeminent makers of Covid-19 vaccines—saw over $10 billion in new wealth, with the Moderna's CEO alone adding over $800 million to his personal fortune. --- If you like what we do please do the following! Most Independent Media outlets continue to struggle to raise the funds they need to operate much like the smaller outlets like Politics Done Right SUBSCRIBE to our YouTube Channel here. LIKE our Facebook Page here. Share our blogs, podcasts, and videos. Get our books here. Become a YouTube PDR Posse Member here. Become a Politics Done Right Subscriber via Patreon here. Become a Politics Done Right Subscriber via Facebook here. Consider providing a contribution here. Please consider supporting our GoFundMe equipment fund here. --- Send in a voice message: https://anchor.fm/politicsdoneright/message Support this podcast: https://anchor.fm/politicsdoneright/support

PART 2- Understanding the Complexities U.S. Drug Price ContractingThere has been a ton of talk about the need for “transparent pricing,” as well as controlling the cost of drugs in the US. There seems to be a lot of finger pointing going on and it often looks like the providers and the manufacturers are taking a lot of the heat…!?Our special guest today is Antonio Ciaccia, Chief Strategy Officer and Co-Founder, of 3 Axis Advisors. I had the privilege of hearing Antonio speak at a recent Midwest Business Group on Health webinar, and I asked Antonio to please help us understand the complexities of the drug distribution channel and how this system can really muddy the waters in our pursuit of more transparency in this segment of the healthcare system.Please note that the views and opinions expressed by the guest(s) on this episode, are those of the guest(s), and do not necessarily represent the official policy or position of The Kinetix Group and our staff, clients, or customers.www.TKGOncology.com

Antonio has since spent years studying the pharmacy marketplace, publishing several analyses on the drug pricing code and pulling the rug out from what he believes is one of the most dysfunctional marketplaces in the world.

PART 1 - Understanding the Complexities of US Drug Price Contracting There has been a ton of talk about the need for “transparent pricing,” as well as controlling the cost of drugs in the US. There seems to be a lot of finger pointing going on and it often looks like the providers and the manufacturers are taking a lot of the heat…!?Our special guest today is Antonio Ciaccia, Chief Strategy Officer and Co-Founder, of 3 Axis Advisors. I had the privilege of hearing Antonio speak at a recent Midwest Business Group on Health webinar, and I asked Antonio to please help us understand the complexities of the drug distribution channel and how this system can really muddy the waters in our pursuit of more transparency in this segment of the healthcare system.Please note that the views and opinions expressed by the guest(s) on this episode, are those of the guest(s), and do not necessarily represent the official policy or position of The Kinetix Group and our staff, clients, or customers.www.TKGOncology.com

Photo Radar or Red Light Camera Tickets. Antonio Ciaccia, President of 3 Axis Advisors: prescription medications/Pharmacy Benefit Managers (PBMs). Shana Sutton, Blogger at Our Sutton Place: Barney Butter. James Mayo: SOS Hydration.

Why are American prescription drug prices so OUTRAGEOUS? Please welcome Anthony Ciaccia from 3 Axis Advisors on Health Solutions with Shawn and Janet Needham to explain PBMs and their role in price gouging the cost of prescriptions for Americans. You'll learn • How PBMs became yet another middle man in healthcare • Shocking facts on why PBMs have such conflicts of interest! • Why Big Pharma FEARS free market competition • Why insulin prices are so high in America (but not everywhere in America...) ~ Chapters ~ 0:00 Intro 1:03 Anthony's Background 3:30 What Are PBMs? 6:47 How PBMs Rip Off Consumers 11:45 How Can We Fix This? 15:52 Why is Insulin Expensive? 20:44 How Competition Affects Pricing 23:28 Do PBMs Have Your Interest In Mind? 25:22 PBM Conflicts of Interest 31:25 3 Axis Advisors 32:53 Anthony's Passion 34:55 Contact Anthony 35:24 Outro ~ Episode Resources... https://www.3axisadvisors.com/ https://www.46brooklyn.com/ https://www.linkedin.com/in/antonio-ciaccia-390879b/ ~ #AnthonyCiaccia #3AxisAdvisors #HealthcareTransparency #InsulinPrices #AffordableHealthcare #FreeMarketHealthcare #Healthcare #Liberty #EducateAndEmpower #NeedhamHealthSolutions #TeamNeedham #Boise #IdahoFalls #Tricities #JohnStossel #SiouxFalls #KristiNoem #Wenatchee #ShawnNeedham #HealthSolutions #MosesLakeProfessionalPharmacy #MLRX #SickenedTheBook #ShawnNeedhamRPh #ThinkOutsideTheSystem #OptimalHealthMatters #ItsTime ~ *** #BenShapiro & #DaveRamsey Fans. Learn how to be in the driver's seat for your healthcare choices {not the system or doctors!}

This week we speak with Antonio Ciaccia, the President of 3 Axis Advisors, about how he helped uncover $244 million in PBM spread pricing in Ohio Medicaid. We also speak about the laws that are being proposed that could reduce drug costs at the pharmacy counter and other policy solutions that can bring down patient drug costs.

Whenever a pharmacist runs for office, there's usually a good back story that finally made them take the leap from pharmacist to political candidate. Shane Abbott is no exception. Always humble in his demeanor, Shane decided to run for a soon to be vacant Florida House seat after years of being pushed by his friends along with years of advocating for the profession and patients. Shane is a down to Earth person, who is truly looking to make things better in Florida and drive down state spending. www.VoteShaneAbbott.com https://www.facebook.com/abbottforflorida 3 Axis Advisors report on Florida Medicaid: https://www.3axisadvisors.com/projects/2020/1/29/sunshine-in-the-black-box-of-pharmacy-benefits-management

On this episode of Leadership Lessons in Health-System Pharmacy you will hear from Antonio Ciaccia, as we discuss Leadership Strategy Implications for the Changing Pharmacy Landscape. After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management. He rejoined the pharmacy world, heading up government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency and growing the role of the pharmacist. Antonio has spent years working to crack the drug pricing code through his consulting firm, 3 Axis Advisors, and dedicates a substantial portion of his time educating the public about prescription drug prices through 46brooklyn Research, a non-profit organization he co-founded in 2018. He was recently named as the Senior Advisor for Disruptive Innovation & Practice Transformation for the American Pharmacists Association.

Antonio Ciaccia of 3 Axis Advisors and 46brooklyn Research, has recently been named Senior Advisor for Disruptive Innovation and Practice Transformation at the American Pharmacists Association.

PUTTCast Host & Executive Director of PUTT - Monique Whitney talks with:  Kevin Dwayne - Jacksonville FL w/ Panama Rx  Jay Wright - Cocoa FL w/ 5 Points Pharmacy  Amy Rodgers - Little Rock AR  w/ City Pharmacy  A new Florida study, released last week, found that major health care companies using pharmacy benefit managers (PBM's) have positioned themselves to pocket millions of dollars from the state's Medicaid system that were intended to lower costs for millions of low-income Floridians. The study found that despite processing less than half of one percent of all pharmacy claims, specialty pharmacies affiliated with PBM's managed to collect 28 percent of the available profit margin from dispensing prescription drugs. The study was commissioned by the Florida Pharmacy Association and American Pharmacy Cooperative Inc. using data obtained from Florida's Agency for Health Care Administration (AHCA) by the Small Business Pharmacies Aligned for Reform.  Smaller pharmacy operators say the report proves that larger, vertically integrated companies that use PBM's are using “predatory” business practices that short-circuit the free market. State lawmakers expressed alarm at the news and underscored the need for greater transparency and oversight when it comes to PBMs' role in Florida, particularly regarding situations where PBM's and managed care companies own the pharmacies where they direct patients. “Markets fail when markets get corrupted and that is what has happened here. When the middleman is allowed to own the end-retailer then the middlemen's incentive to manage cost appropriately for the benefit of the chain is broken,” said State Representative Randy Fine at a press conference to discuss the study. According to the study, vertically integrated health care companies – that is, companies where the health insurance company and PBM also control their own pharmacies – have a significant advantage in prescription drug pricing and reimbursement rates over smaller pharmacy operations that only focus on dispensing prescription drugs. These large and powerful organizations then use their leverage and contracts with the state to squeeze dollars from their competitors by requiring patients to go to pharmacies where they have a financial interest. This process frequently involves rewarding their own pharmacy operations with significantly higher reimbursement rates from Medicaid, according to the study. The study provided an example of this situation where Sunshine Health directed 95 percent of all claims for generic cancer drug Gleevac to Acaria, its wholly owned specialty pharmacy. It reimbursed this speciality pharmacy an average of $4,399 above the national average cost for the drug. “We have a responsibility to assure that there is no manipulation of prices or anti-competitive practices by PBMs and other entities that result in increased costs to patients and push our local pharmacies out of business,” said State Senator Gayle Harrell. Small pharmacy operations describe PBMs as shadowy prescription drug middlemen whose practices are driving neighborhood pharmacies out of business while reducing access to care for many Floridians. The State of Florida contracts with PBMs to manage Florida's Medicaid program in order to negotiate lower drug prices. But the new study concludes that PBMs have actually cost the public millions of dollars by forcing patients to use PBM-affiliated pharmacies and then charging higher prescription costs. According to Medicaid data contained in the study, one pharmacy in North Miami was responsible for 25% of all managed care claims in Florida for a particular dermatological cream in 2018, receiving a total profit margin of over $1.8 million. The independent study by 3 Axis Advisors reviewed more than 359 million prescription drug claims within Florida's Medicaid program between 2012 and 2019. The information from AHCA was coupled with data from more than 100 pharmacies to determine the impact PBMs have on the portion of the health care system paid by Florida taxpayers through the Medicaid program. See omnystudio.com/listener for privacy information.

IN DATA WE TRUST Special Guest: ANTONIO CIACCIA with 3 Axis Advisors.  Born and raised in pharmacy, Antonio has been crawling around pharmacies his entire life.  After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management. Thinking that pharmacy would be in his rear-view mirror forever, he ended up making his way back to his pharmacy home, heading up government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. See omnystudio.com/listener for privacy information.

IN DATA WE TRUST Special Guest: ANTONIO CIACCIA with 3 Axis Advisors.  Born and raised in pharmacy, Antonio has been crawling around pharmacies his entire life.  After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management. Thinking that pharmacy would be in his rear-view mirror forever, he ended up making his way back to his pharmacy home, heading up government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices